October 2017 marks the 33rd anniversary of National Breast Cancer Awareness Month since its inception in 1985 by the American Cancer Society. Breast cancer care is "ubiquitous" in our health system, as the management of breast disease involves many different specialties, spans a variety of health care settings, and crosses the full cancer spectrum from prevention, screening, treatment, and survivorship, to end of life. Given the high incidence of breast cancer, together with its inherent complexity and cost, some argue that the quality of breast care serves as a meaningful barometer for the quality of the overall health system. With that in mind, there are significant implications for monitoring the effectiveness of breast care and guiding quality improvement.
Several implementations in breast cancer quality have been responsible for advancing outcomes in breast care. These include efforts focused on multidisciplinary care, patient navigation, shared decision making, evidencebased guidelines, public awareness, and outcomes registries. More patterns-of-care research has taken place in breast cancer than in any other oncologic condition. Performance metrics in breast care have traditionally focused on structure (eg, multidisciplinary teams, patient volumes), process (eg, administration of radiation following breast-conserving surgery), and outcomes (eg, disease-free and overall survival). Continued strides in the quality of breast cancer care will require us to move ever closer to the end results directly affecting patients, and outcomes that matter most to breast cancer survivors. Patients often prioritize outcomes that differ from those prioritized by clinicians. For example, a recent study identified that patients valued the avoidance of severe pain greater than a 2-year improvement in survival. 1 Another study demonstrated how asymmetry following breast surgery increased anxiety and fear of death from cancer recurrence. 2 In one study, time delays in receiving biopsy results led to significant increases in markers of biochemical distress monitored in patients. 3 The future of quality improvement in breast cancer will require an even greater focus on patient-centered factors affecting patient experience and clinical outcomes. Systematically collected patient-reported outcomes (PROs) will be critical to accomplish this goal.
Patient-Reported Outcomes
PROs have been defined as "any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else." PROs should not be confused with patient-reported experience measures, which focus on a patient's overall experience rather than specific treatment outcomes. PRO measures (PROMs) can be used to generate data points including, but not limited to, perceptions of emotional well-being, physical function, body image, social functioning, symptom management, change in health status, overall quality of care, and health outcomes. [4] [5] [6] [7] [8] [9] [10] PROs carry great predictive capacity and can provide important information about patient status between medical visits, allowing clinicians to promptly intervene to address care needs and make necessary adjustments to the care plan in real time. 7, 11, 12 For example, integrating PROs into routine cancer care in the form of email alerts to oncology nurses improved patient-clinician communication, symptom management, and quality of life. As a result, there were reductions in emergency room visits, longer tolerability of chemotherapy, and improved survival. 13 BREAST-Q, EORTC QLQ-C30, EORTC QLQ-BR-23, and FACT-B, which are readily available for use. 5, 6, 10 Each instrument has specific strengths and weaknesses, and their use can be tailored depending on the variables intended. 6, 10 There is a strong need to understand how to interpret and apply the information that is gathered in an optimal way. 7 There also is a need for greater compatibility and standardization so that data can be compared for groups of patients. 12 To date, little is known about aggregating these patient-level outcomes for measuring performance of the health care entity delivering care. Finally, privacy concerns for data capture and storage need to be addressed in a robust manner. 7 As clinicians and designers of these systems, we must be thoughtful about the complexity, time needed for completion, and availability of translated and culturally sensitive options. 4, 7 Current clinical processes ask more of clinicians and patients through intake forms, screening questionnaires, patient experience and satisfaction surveys, clinical data entry, research studies, and more. Increasingly, stakeholders begin to doubt the value of the time spent providing this information. Without further engagement and education, patients and clinicians alike are likely to approach PROMs warily. The key is to make it easy, make it fast, and make it relevant. Adapting existing technology (eg, electronic health records [EHRs], patient portals, health apps) will enable rapid data collection, trending of results, and actionable data analysis. This requires an electronic platform with a simplified patient interface, and seamless integration into the EHR, so that results flow into the point of care in real time. 7, 12, 14 The concept of computer-adaptive testing, which would allow individually tailored questions based on previous responses, also may increase patient adherence to PRO initiatives. 9, 11 The increasing presence of smartphones, mobile applications, high-speed Internet connections, and remote monitoring devices, coupled with secure messaging, offer innovative opportunities to connect patients with members of the care team and enhance patient engagement in selfcare. In the near future, a patient undergoing treatment for breast cancer may have home sensors that automatically collect and transmit patient-generated data to secure servers at the patient's treating medical center. Through machine learning, algorithms process the data to understand living habits and home movements to identify low activity, decreased oral intake, nonadherence to medication, and other changes that may indicate a deteriorating condition and/or impending complication. The system then automatically alerts the oncology care team (and patient), and appropriate action is taken as early as possible.
Implementation

Future of PROs
PROs will be used to improve health care delivery, optimize clinical outcomes, monitor treatment progress, and individualize care. 11, 12 The collection of PROs is felt to be a valuable "next-generation" quality measure and may soon become part of the Medicare Meaningful Use Program, thus tying reimbursement to these data. These concepts also are gaining the support of professional medical societies, as well as the National Institutes of Health, as an important quality initiative. 11 We as a community need to know which outcomes are of value to our patients, 4, 7, 14 and develop the means to readily collect and act on this information. This will only be accomplished by fully partnering with our patients in the design of PRO tools and databases. 1, 7 The development of treatmentspecific PRO registries to capture data prospectively through the use of self-assessment tools will greatly inform patient-centered quality improvement efforts on regional and national levels. 7, 8, 11 The opportunity to connect PROs on a patient level with large treatment and outcomes databases such as the National Cancer Database, or SEER (Surveillance, Epidemiology, and End Results), would allow the analysis of how particular treatment choices and survival are correlated with PROs, potentially allowing for unique approaches to interventions going forward. By making PROMs an integral part of clinical care, health care professionals can use the data to improve individual patient care, as well as the care of populations. Patients would also have meaningful data to assist self-care.
As patients with breast cancer progress through treatment and survivorship, it becomes increasingly important to learn from their experiences and understand their journey from their own perspective. 9, 14 The collection and analysis of PROs offers a unique opportunity to better understand clinical outcomes, correlate PROs with specific treatment paradigms and survival, and establish models of goal-directed quality care based on effective interventions. 9 In this manner, value-based clinical care may be improved for the patient, thereby providing greater satisfaction with their health care and improving their quality of life.
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